Angiotensin II receptor antagonists (AT

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research.Biosensors · 2026
   Review
2. Angiotensin II receptor blockers induce autophagy in prostate cancer cells.Oncology letters · 2017
   Article
3. Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition.Pharmaceuticals (Basel, Switzerland) · 2015
   Article
4. Angiotensin II receptor blockers: a new possible treatment for chronic migraine?Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2015
   Article
5. Drug Interactions in Parkinson's Disease: Safety of Pharmacotherapy for Arterial Hypertension.Drugs - real world outcomes · 2015
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as